The copper intrauterine device and its mode of action.
D000818:Animals; D055598:Chemical Phenomena; D002621:Chemistry; D003300:Copper / Q000009:adverse effects / Q000494:pharmacology; D003864:Depression, Chemical; D010064:Embryo Implantation / Q000187:drug effects; D004717:Endometrium / Q000187:drug effects / Q000378:metabolism; D005260:Female; D005306:Fertilization / Q000187:drug effects; D006801:Humans; D007434:Intrauterine Devices; D007436:Intrauterine Devices, Medicated / Q000009:adverse effects; D007477:Ions; D008297:Male; D010084:Oxidation-Reduction; D010100:Oxygen; D011247:Pregnancy; D011460:Prostaglandins F / Q000096:biosynthesis; D012965:Sodium Chloride; D013094:Spermatozoa / Q000187:drug effects; D013268:Stimulation, Chemical; D014590:Uterine Contraction / Q000187:drug effects; D014599:Uterus / Q000378:metabolism
D007477:Ions; D011460:Prostaglandins F; D012965:Sodium Chloride; D003300:Copper; D010100:Oxygen